News|Articles|February 2, 2005
- Pharmaceutical Technology-02-02-2005
- Volume 29
- Issue 2
Using Extrusion-Spheronization to Develop Controlled-Release Formulations of Azithromycin
Extrusion-spheronization and pellet compression are effective means of developing first-order kinetic, controlled-release drug delivery systems of azithromycin (AZI). The authors prepared, evaluated, and optimized AZI formulations and assessed the stability of the selected formulation under accelerated storage conditions.
Advertisement
Articles in this issue
about 21 years ago
Correcting the Courseabout 21 years ago
February 2005about 21 years ago
Good Work and True: USP Prepares for Convention 2005about 21 years ago
Contract Manufacturers Getting Squeezedabout 21 years ago
In the Spotlight-February 2005about 21 years ago
Emerging Analytical Technology: Moving from the Lab to the Lineabout 21 years ago
Drug Safety Fears May Limit Reimporting and Shape R&Dabout 21 years ago
In Defense of USP Singlet TestingNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Women in STEM: Early Phase Drug Development
2
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
3
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B
4
PharmTech Weekly Roundup - February 6, 2026
5